101 related articles for article (PubMed ID: 10790996)
1. [Salvage chemotherapy in refractory testicular cancer].
Nakao M; Nomoto T; Mizutani Y; Miki T
Gan To Kagaku Ryoho; 2000 Apr; 27(4):542-7. PubMed ID: 10790996
[TBL] [Abstract][Full Text] [Related]
2. The role of ifosfamide in the treatment of testicular and urothelial malignancies.
Roth BJ
Semin Oncol; 1996 Jun; 23(3 Suppl 7):19-27. PubMed ID: 8711497
[TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
4. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
Ronnen EA; Kondagunta GV; Bacik J; Marion S; Bajorin DF; Sheinfeld J; Bosl GJ; Motzer RJ
J Clin Oncol; 2005 Oct; 23(28):6999-7004. PubMed ID: 16192587
[TBL] [Abstract][Full Text] [Related]
5. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
[TBL] [Abstract][Full Text] [Related]
6. [Salvage therapy for refractory testicular cancer].
Kawai K; Akaza H
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1129-35. PubMed ID: 8751799
[TBL] [Abstract][Full Text] [Related]
7. [Current status and future perspectives in chemotherapy for testicular cancer].
Kawai K
Gan To Kagaku Ryoho; 2003 Feb; 30(2):171-80. PubMed ID: 12610862
[TBL] [Abstract][Full Text] [Related]
8. [The salvage chemotherapy for refractory testicular cancer with novel anticancer agents].
Miki T; Nomoto T; Nakagawa S; Nakao M; Nonomura N; Takada T; Saiki S; Kotake T
Hinyokika Kiyo; 1999 Nov; 45(11):811-4. PubMed ID: 10637749
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
Rick O; Siegert W; Beyer J
Cancer Treat Rev; 2001 Oct; 27(5):283-8. PubMed ID: 11871864
[TBL] [Abstract][Full Text] [Related]
10. [Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].
Tanji S; Obara W; Sugimura J; Ohmori S; Matsushita Y; Tokunaga H; Konda R; Fujioka T; Murai K; Ishida Y
Hinyokika Kiyo; 2004 Feb; 50(2):77-80. PubMed ID: 15101160
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
Nonomura N; Oka D; Nishimura K; Nakayama M; Inoue H; Mizutani Y; Miki T; Okuyama A
Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098
[TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Miki T; Mizutani Y; Akaza H; Ozono S; Tsukamoto T; Terachi T; Naito K; Nonomura N; Hara I; Yoshida O;
Int J Urol; 2007 Jan; 14(1):54-9. PubMed ID: 17199861
[TBL] [Abstract][Full Text] [Related]
14. Recent strategy for the management of advanced testicular cancer.
Nakamura T; Miki T
Int J Urol; 2010 Feb; 17(2):148-57. PubMed ID: 20377835
[TBL] [Abstract][Full Text] [Related]
15. [Salvage chemotherapy for advanced testicular cancer].
Nakamura T; Miki T
Hinyokika Kiyo; 2012 Dec; 58(12):721-5. PubMed ID: 23328173
[TBL] [Abstract][Full Text] [Related]
16. Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors.
Mardiak J; Fuchsberger P; Lakota J; Sálek T; Sycová-Milá Z; Drahokoupilová M; Baláz M; Koza I
Neoplasma; 2000; 47(4):239-43. PubMed ID: 11043829
[TBL] [Abstract][Full Text] [Related]
17. Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
Kollmannsberger C; Bokemeyer C
Curr Opin Support Palliat Care; 2008 Sep; 2(3):167-72. PubMed ID: 18685416
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Zinzani PL; Tani M; Molinari AL; Stefoni V; Zuffa E; Alinari L; Gabriele A; Bonifazi F; Salvucci M; Tura S; Baccarani M
Haematologica; 2002 Aug; 87(8):816-21. PubMed ID: 12161357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
